As of 2:30 PM on the 31st, Access Bio is trading at 26,200 KRW, down 2.06% from the previous day. This represents a 47.34% decline compared to August 19. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past five days, individual investors have net purchased 514,398 shares, while foreigners and institutions have net sold 63,601 shares and 491,776 shares, respectively.


On August 24, Access Bio became a market issue with the headline "Two consecutive trading days of sharp decline... from the 60,000 KRW range down to the 20,000 KRW range."



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing